Currently viewing the tag: "genetics"

The 2013-2014 JETLaw Symposium, “Patents 101: Eligibility from Computer Code to Genetic Codes” will be held at Vanderbilt Law School on Friday, January 24th, 2014. The Symposium examines the interaction of Section 101 and patent eligibility of software and DNA, as well as the implication of current jurisprudence on patent eligible [...]

Continue Reading

As Americans become more likely to buy products based on green and health-conscientious labels, many companies have tried to capitalize on these new marketing strategies. But these campaigns are not without risk. Despite highly interpretative FDA guidance on “all-natural” products, some litigants are willing to take on major corporations.

In one high-profile [...]

Continue Reading

The story unfolds like a hybrid horror or science fiction film: a serial killer called the Grim Sleeper preys on prostitutes and drug addicts, murdering them and disposing of their bodies in dumpsters and alleyways in a south Los Angeles neighborhood. The deranged man kills at least seven women in the mid-1980’s and then [...]

Continue Reading

The United States District Court for the Southern District of New York faced a difficult question at the intersection of law and biotechnology last month: can one patent nature? On Monday, March 29, United States District Court Judge Robert W. Sweet said no, and invalidated seven patents related to the BRCA1 and BRCA2 genes, the [...]

Continue Reading